HLB Genex Statistics

Total Valuation

HLB Genex has a market cap or net worth of KRW 102.56 billion. The enterprise value is 67.78 billion.

Market Cap	102.56B
Enterprise Value	67.78B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

HLB Genex has 29.14 million shares outstanding. The number of shares has increased by 4.10% in one year.

Current Share Class	29.14M
Shares Outstanding	29.14M
Shares Change (YoY)	+4.10%
Shares Change (QoQ)	+6.80%
Owned by Insiders (%)	12.56%
Owned by Institutions (%)	2.24%
Float	18.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.89
PB Ratio	3.63
P/TBV Ratio	4.56
P/FCF Ratio	46.17
P/OCF Ratio	35.73
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.67, with an EV/FCF ratio of 30.51.

EV / Earnings	-3.60
EV / Sales	1.91
EV / EBITDA	25.67
EV / EBIT	n/a
EV / FCF	30.51

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 1.58.

Current Ratio	1.07
Quick Ratio	1.01
Debt / Equity	1.58
Debt / EBITDA	16.88
Debt / FCF	20.07
Interest Coverage	-0.43

Financial Efficiency

Return on equity (ROE) is -62.18% and return on invested capital (ROIC) is -1.40%.

Return on Equity (ROE)	-62.18%
Return on Assets (ROA)	-0.95%
Return on Invested Capital (ROIC)	-1.40%
Return on Capital Employed (ROCE)	-3.33%
Revenue Per Employee	506.14M
Profits Per Employee	-268.97M
Employee Count	70
Asset Turnover	0.29
Inventory Turnover	3.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.31% in the last 52 weeks. The beta is 0.10, so HLB Genex's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	-17.31%
50-Day Moving Average	3,661.40
200-Day Moving Average	3,835.65
Relative Strength Index (RSI)	49.10
Average Volume (20 Days)	46,424

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HLB Genex had revenue of KRW 35.43 billion and -18.83 billion in losses. Loss per share was -800.03.

Revenue	35.43B
Gross Profit	14.30B
Operating Income	-1.85B
Pretax Income	-16.90B
Net Income	-18.83B
EBITDA	2.64B
EBIT	-1.85B
Loss Per Share	-800.03

Full Income Statement

Balance Sheet

The company has 83.81 billion in cash and 44.57 billion in debt, giving a net cash position of 39.23 billion or 1,346.57 per share.

Cash & Cash Equivalents	83.81B
Total Debt	44.57B
Net Cash	39.23B
Net Cash Per Share	1,346.57
Equity (Book Value)	28.22B
Book Value Per Share	815.82
Working Capital	6.59B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.87 billion and capital expenditures -648.89 million, giving a free cash flow of 2.22 billion.

Operating Cash Flow	2.87B
Capital Expenditures	-648.89M
Free Cash Flow	2.22B
FCF Per Share	76.24

Full Cash Flow Statement

Margins

Gross margin is 40.36%, with operating and profit margins of -5.21% and -53.14%.

Gross Margin	40.36%
Operating Margin	-5.21%
Pretax Margin	-47.69%
Profit Margin	-53.14%
EBITDA Margin	7.45%
EBIT Margin	-5.21%
FCF Margin	6.27%

Dividends & Yields

HLB Genex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.10%
Shareholder Yield	-4.10%
Earnings Yield	-18.36%
FCF Yield	2.17%

Stock Splits

The last stock split was on March 19, 2018. It was a forward split with a ratio of 2.

Last Split Date	Mar 19, 2018
Split Type	Forward
Split Ratio	2

Scores

HLB Genex has an Altman Z-Score of 0.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.14
Piotroski F-Score	n/a